Computed tomography (CT) is one of the most commonly used clinical imaging modalities. There have recently been many reports of novel contrast agents for CT imaging. In particular, the development of gold nanoparticles (AuNP) as CT contrast agents is a topic of intense interest. AuNP have favorable characteristics for this application such as high payloads of contrast generating material, strong X-ray attenuation, excellent biocompatibility, tailorable surface chemistry, and tunable sizes and shapes. However, there have been conflicting reports on the role of AuNP size on their contrast generation for CT. We therefore sought to extensively investigate the AuNP size-CT contrast relationship. In order to do this, we synthesized AuNP with sizes ranging from 4 to 152 nm and capped them with 5 kDa m-PEG. The contrast generation of AuNP of different sizes was investigated with three clinical CT, a spectral photon counting CT (SPCCT) and two micro CT systems. X-ray attenuation was quantified as attenuation rate in Hounsfield units per unit concentration (HU/mM). No statistically significant difference in CT contrast generation was found among different AuNP sizes via phantom imaging with any of the systems tested. Furthermore, in vivo imaging was performed in mice to provide insight into the effect of AuNP size on animal biodistribution at CT dose levels, which has not previously been explored. Both in vivo imaging and ex vivo analysis with inductively coupled plasma optical emission spectroscopy (ICP-OES) indicated that AuNP that are 15 nm or smaller have long blood circulation times, while larger AuNP accumulated in the liver and spleen more rapidly. Therefore, while we observed no AuNP size effect on CT contrast generation, there is a significant effect of size on AuNP diagnostic utility.

Earlier detection of breast cancer reduces mortality from this disease. As a result, the development of better screening techniques is a topic of intense interest. Contrast-enhanced dual-energy mammography (DEM) is a novel technique that has improved sensitivity for cancer detection. However, the development of contrast agents for this technique is in its infancy. We herein report gold-silver alloy nanoparticles (GSAN) that have potent DEM contrast properties and improved biocompatibility. GSAN formulations containing a range of gold:silver ratios and capped with m-PEG were synthesized and characterized using various analytical methods. DEM and computed tomography (CT) phantom imaging showed that GSAN produced robust contrast that was comparable to silver alone. Cell viability, reactive oxygen species generation and DNA damage results revealed that the formulations with 30% or higher gold content are cytocompatible to Hep G2 and J774A.1 cells. In vivo imaging was performed in mice with and without breast tumors. The results showed that GSAN produce strong DEM and CT contrast and accumulated in tumors. Furthermore, both in vivo imaging and ex vivo analysis indicated the excretion of GSAN via both urine and feces. In summary, GSAN produce strong DEM and CT contrast, and has potential for both blood pool imaging and for breast cancer screening.

Computed tomography (CT) is an X-ray-based medical imaging technique commonly used for noninvasive gastrointestinal tract (GIT) imaging. Iodine- and barium-based CT contrast agents are used in the clinic for GIT imaging; however, inflammatory bowel disease (IBD) imaging is challenging since iodinated and barium-based CT agents are not specific for sites of inflammation. Cerium oxide nanoparticles (CeNP) can produce strong X-ray attenuation due to cerium’s k-edge at 40.4 keV but have not yet been explored for CT imaging. In addition, we hypothesized that the use of dextran as a coating material on cerium oxide nanoparticles would encourage accumulation in IBD inflammation sites in a similar fashion to other inflammatory diseases. In this study, therefore, we sought to develop a CT contrast agent, i.e., dextran-coated cerium oxide nanoparticles (Dex-CeNP) for GIT imaging with IBD. We synthesized Dex-CeNP, characterized them using various analytical tools, and examined their in vitro biocompatibility, CT contrast generation, and protective effect against oxidative stress. In vivo CT imaging was done with both healthy mice and a dextran sodium sulfate induced colitis mouse model. Dex-CeNP’s CT contrast generation and accumulation in inflammation sites were compared with iopamidol, an FDA approved CT contrast agent. Dex-CeNP was found to be protective against oxidative damage. Dex-CeNP produced strong CT contrast and accumulated in the colitis area of large intestines. In addition, >97% of oral doses were cleared from the body within 24 h. Therefore, Dex-CeNP can be used as a potential CT contrast agent for imaging GIT with IBD while protecting against oxidative damage.

The reduction of 4-nitrophenol to 4-aminophenol by sodium borohydride serves as a well-established model reaction for assessing the catalytic activity of metal nanoparticles. While many of the studied nanoparticles are plasmonic in nature, there is little understanding of whether significant photocatalytic enhancements to the reaction rate are achievable. Here, we assess the catalytic and photocatalytic properties of highly faceted, substrate-immobilized nanoprism-like AuCu structures synthesized using a vapor phase templated-assembly technique.The so-formed structures have a bimetallic composition which is well-recognized for its catalytic capabilities as well as a strong localized surface plasmon resonance in the visible spectrum which gives rise to enhanced near-fields at the tips of the triangle. Using a dip catalyst modality, the structures are demonstrated as heterogeneous photocatalysts with a 32-fold enhancement to the reaction rate when resonantly illuminated with 10 mW/cm 2 laser light. The study demonstrates the potential of such structures as photocatalysts and validates the reduction of 4-nitrophenol as a reaction useful in assessing the photocatalytic capabilities of plasmonic nanostructures.

No abstract

Galvanic replacement reactions carried out on solid core-shell structures typically yield a noble metal nanorattle geometry in which a mobile core is contained within a hollowed shell. Here, we adapt this colloidal synthesis to substrate-based structures to obtain a fundamentally altered product in which an immobilized core is separated from the shell by a well-defined gap, an architecture unobtainable using colloidal techniques and that offers unique advantages in terms of generating plasmonic near-field effects within the confines of a single structure. In the devised route, Wulff-shaped templates of Au, Pt, or Pd, formed through the dewetting of ultrathin films, are first transformed into core-shell structures through the reduction of Ag(+) ions onto their surface and then further transformed through the galvanic replacement of Ag with Au. Through suitable adjustments to the shell geometry, the epitaxial relationship with the substrate, and the extent to which the shell is replaced, it is possible to generate an entire family of nanostructures in which a Wulff-shaped core is confined within a nanoshell, nanocage, or nanoframe, where, in all cases, bonds formed between the structure and the substrate preclude motion. With the potential to tune the gap width, the geometry of the confining structure, and the composition of the core, shell, and substrate, these structures could find application as catalytic nanoreactors able to drive both single-step and cascade reactions or as plasmon-based sensing elements for biological and chemical detection.

Seed-mediated syntheses utilizing facet-selective surface passivation provide the necessary chemical controls to direct noble metal nanostructure formation to a predetermined geometry. The foremost protocol for the synthesis of (111)-faceted Ag octahedra involves the reduction of metal ions onto pre-existing seeds in the presence of citrate and ascorbic acid. It is generally accepted that the capping of (111) facets with citrate dictates the shape while ascorbic acid acts solely as the reducing agent. Herein, a citrate-based synthesis is demonstrated in which the presence or absence of ascorbic acid is the shape-determining factor. Reactions are carried out in which Ag(+) ions are reduced onto substrate-immobilized Ag, Au, Pd, and Pt seeds. Syntheses lacking ascorbic acid, in which citrate acts as both the capping and the reducing agent, result in a robust nanocube growth mode able to withstand wide variations in the concentration of reactants, reaction rates, seed material, seed orientation and faceting, pH, and substrate material. If, however, ascorbic acid is included in these syntheses, then the growth mode reverts to one that advances the octahedral geometry. The implication of these results is that citrate, or one of its oxidation products, selectively caps (100) facets, but where this capability is compromised by ascorbic acid.

Modern technologically driven societies could not exist in their current form if it were not for a great many synthetic achievements reliant on solution-based chemistry and substrate-based processing techniques. It is, hence, not surprising that these same materials preparation techniques have given rise to an impressive list of functional nanomaterials including those derived from noble metals, a class of materials renowned for their extraordinary optical and catalytic properties. Acting as the foundation for substrate-based processing is a collection of techniques such as physical and chemical vapor deposition, epitaxy, self- and directed assembly, and a host of lithographic methods. These techniques allow for precise control over nanostructure placement, but where the fabrication of sophisticated architectures and sub-50 nm feature sizes are often unattainable or reliant on the use of technically demanding cost-prohibitive routes. In contrast, solution-based chemistry allows for the formation of complex nanostructures while maintaining synthetic ease, cost-effectiveness, and exacting control over monodispersity, size, shape, composition, and crystallinity. While many methods exist for the dispersal of colloids onto substrates, few are capable of achieving nanostructure ensembles where nanostructure placement allows for true long-range order as well as control over the crystallographic alignment of the nanostructures relative to each other and the underlying substrate. A more exhaustive comparison of these two approaches reveals that, more often than not, a weakness of substrate-based processing is a strength of colloidal synthesis and vice versa. In this Account, we describe a synthetic strategy devised and validated by the Neretina laboratory that integrates the competencies of substrate-based techniques with colloidal chemistry and, in doing so, brings this rich and exciting chemistry and its associated functionalities to the substrate surface. The strategy takes advantage of an impressive collection of seed-mediated solution-based protocols in which dispersed seeds direct noble metal nanostructure formation along orderly reaction pathways. It, however, replaces the seed colloid with substrate-immobilized templates formed in periodic arrays where the crystallographic orientation of the templates is defined by an epitaxial relationship with the substrate. Demonstrated are syntheses at the liquid-substrate interface in which organized surfaces of crystalline templates formed through templated dewetting are subjected to galvanic replacement, preferential etching, and/or heterogeneous deposition facilitated by redox reactions in both the presence and absence of capping agents. While the protocols utilized are adapted from some of the most well-studied colloidal syntheses, in no case do they yield reaction products that are identical since the substrate inflicts asymmetries onto the growth mode. We believe that the strategy described herein not only demonstrates a family of nanostructures unobtainable through oth...